Literature DB >> 16651329

The epidemiology of meconium aspiration syndrome: incidence, risk factors, therapies, and outcome.

Peter A Dargaville1, Beverley Copnell.   

Abstract

OBJECTIVE: We sought to examine, in a large cohort of infants within a definable population of live births, the incidence, risk factors, treatments, complications, and outcomes of meconium aspiration syndrome (MAS).
DESIGN: Data were gathered on all of the infants in Australia and New Zealand who were intubated and mechanically ventilated with a primary diagnosis of MAS (MASINT) between 1995 and 2002, inclusive. Information on all of the live births during the same time period was obtained from perinatal data registries.
RESULTS: MASINT occurred in 1061 of 2,490,862 live births (0.43 of 1000), with a decrease in incidence from 1995 to 2002. A higher risk of MASINT was noted at advanced gestation, with 34% of cases born beyond 40 weeks, compared with 16% of infants without MAS. Fetal distress requiring obstetric intervention was noted in 51% of cases, and 42% were delivered by cesarean section. There was a striking association between low 5-minute Apgar score and MASINT. In addition, risk of MASINT was higher where maternal ethnicity was Pacific Islander or indigenous Australian and was also increased after planned home birth. Uptake of exogenous surfactant, high-frequency ventilation, and inhaled nitric oxide increased considerably during the study period, with >50% of infants receiving > or =1 of these therapies by 2002. Risk of air leak was 9.6% overall, with an apparent reduction to 5.3% in 2001-2002. The duration of intubation remained constant throughout the study period (median: 3 days), whereas duration of oxygen therapy and length of hospital stay increased. Death related to MAS occurred in 24 infants (2.5% of the MASINT cohort; 0.96 per 100,000 live births).
CONCLUSIONS: The incidence of MASINT in the developed world is low and seems to be decreasing. Risk of MASINT is significantly greater in the presence of fetal distress and low Apgar score, as well as Pacific Islander and indigenous Australian ethnicity. The increased use of innovative respiratory supports has not altered the duration of mechanical ventilation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651329     DOI: 10.1542/peds.2005-2215

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  34 in total

1.  Bacteria and endotoxin in meconium-stained amniotic fluid at term: could intra-amniotic infection cause meconium passage?

Authors:  Roberto Romero; Bo Hyun Yoon; Piya Chaemsaithong; Josef Cortez; Chan-Wook Park; Rogelio Gonzalez; Ernesto Behnke; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

2.  Surfactant reduced the mortality of neonates with birth weight ⩾1500 g and hypoxemic respiratory failure: a survey from an emerging NICU network.

Authors:  H Wang; X Gao; C Liu; C Yan; X Lin; Y Dong; B Sun
Journal:  J Perinatol       Date:  2017-02-02       Impact factor: 2.521

3.  Meconium aspiration syndrome requiring ECMO in newborns with gastroschisis: incidence and surgical outcomes.

Authors:  Katie W Russell; Michael L Nance; N Scott Adzick; Pablo Laje
Journal:  Pediatr Surg Int       Date:  2018-11-16       Impact factor: 1.827

4.  Respiratory distress including meconium aspiration syndrome in vigorous neonates born through meconium stained amniotic fluid: incidence, onset, severity and predictors at birth.

Authors:  S N Singh; Roli Srivastava; Anita Singh; M Tahazzul; Mala Kumar; Chandra Kanta; S Chandra
Journal:  Indian J Pediatr       Date:  2012-11-28       Impact factor: 1.967

5.  Meconium aspiration syndrome: a role for fetal systemic inflammation.

Authors:  JoonHo Lee; Roberto Romero; Kyung A Lee; Eun Na Kim; Steven J Korzeniewski; Piya Chaemsaithong; Bo Hyun Yoon
Journal:  Am J Obstet Gynecol       Date:  2015-10-17       Impact factor: 8.661

6.  A study of oxidative stress in neonates delivered through meconium-stained amniotic fluid.

Authors:  Tapas Bandyopadhyay; B D Bhatia; H D Khanna
Journal:  Eur J Pediatr       Date:  2017-01-06       Impact factor: 3.183

7.  Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates.

Authors:  Daniele De Luca; Angelo Minucci; Domenico Tripodi; Marco Piastra; Domenico Pietrini; Cecilia Zuppi; Giorgio Conti; Virgilio P Carnielli; Ettore Capoluongo
Journal:  Intensive Care Med       Date:  2011-05-13       Impact factor: 17.440

8.  Amelioration of meconium-induced acute lung injury by parecoxib in a rabbit model.

Authors:  Ai-Min Li; Li-Na Zhang; Wen-Zhi Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

9.  Secreted phospholipase A2 is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meconium aspiration syndrome.

Authors:  Roberto Romero; Bo Hyun Yoon; Piya Chaemsaithong; Josef Cortez; Chan-Wook Park; Rogelio Gonzalez; Ernesto Behnke; Sonia S Hassan; Francesca Gotsch; Lami Yeo; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-01-06

10.  Meconium Aspiration Syndrome: An Insight.

Authors:  U Raju; V Sondhi; S K Patnaik
Journal:  Med J Armed Forces India       Date:  2011-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.